Genomic & Biopharma NewsNews of Note—A vaccine against opioid addiction; prompting hearts to heal themselves; combating inflammation
The past week brought new discoveries related to treating opioid addiction with a vaccine, reversing heart failure and attacking the inflammation at the root of several diseases.
|Fierce Biotech, 2017-08-21 15:34:34|
Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
|ORB Company News, 2016-12-28 18:58:47|
Amid FDA competition push, Hikma jacks up a handful of drug prices as much as 430%
Generic drug prices may be depressed enough to bring down the mood of many a copycat drugmaker, but that doesn’t mean prices on some unusual formulas aren’t going up. Just ask Hikma, which posted a half-dozen price rises that topped out at 430%.
|Fierce Pharma, 2017-08-21 15:31:18|
Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach
|ORB Company News, 2016-12-02 21:24:27|
Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes
A new study conducted by the UCLA Fielding School of Public Health, states that among nearly 4 million women in the United States who possess a medical history of ovarian cancer or breast cancer, 1.5 million have an increased risk of bearing some kinds of genetic mutations, which might increase the probability of causing additional cancers in the future.
|News Medical Life Sciences, 2017-08-21 14:52:00|
Carl Zeiss boosts digital solutions with cloud-based cataract surgery planning tool
Carl Zeiss Meditec announced its acquisition of Veracity Innovations and its cloud-based platform that provides physicians with quick and easy access to clinical data at each stage of patient care.
|Fierce Biotech, 2017-08-21 14:40:47|
Wild mussels inspire superstrong glue for fetal surgery
The biggest risk involved in performing surgery on a fetus is that the protective amniotic sac must be broken, and repairing it is no easy task. So researchers at the University of California at Berkeley are turning to wild mussels for inspiration.
|Fierce Biotech, 2017-08-21 14:16:48|
Pfizer lashes out at ‘frustrating’ NICE decision on ALL drug Besponsa
Pfizer’s new targeted drug for the treatment of acute lymphoblastic leukemia (ALL) last week won FDA approval after already getting a nod by the EU. But U.K. cost watchdog NICE today snubbed Besponsa, eliciting a quick and heated response from the U.S. drugmaker.
|Fierce Pharma, 2017-08-21 14:12:03|
MiMedx offloads bone graft business to focus on biopharma
MiMedx is divesting Stability Biologics, its bone graft subsidiary, back to its shareholders as it “transitions” into a biopharmaceutical company.
|Fierce Biotech, 2017-08-21 14:07:53|
FDA clears Creo to sell surgical endoscopic device
The FDA has cleared Creo Medical Group to start selling its Speedboat RS2 device in the U.S. Creo designed the device to enable the minimally invasive removal of lesions from the bowel.
|Fierce Biotech, 2017-08-21 14:06:24|
Novel mussel-inspired glue could one day save lives of youngest patients
Whether to perform surgery on a fetus is a heart-wrenching decision. This type of surgery involves penetrating the highly delicate amniotic sac, increasing health risks to the fetus.
|News Medical Life Sciences, 2017-08-21 14:05:40|